# Pfizer Ltd (PFIZER)
> Exchange: NSE | Sector: Pharma | ISIN: INE182A01018

## Price
Current Price: ₹4689.2
Day Change: +0.39%
52W High: ₹5993
52W Low: ₹4405
Market Cap: ₹22,262 Cr

## Valuation
P/E: 30.79
P/B: 5.78
EPS: ₹158.05
Book Value: ₹841.24
Dividend Yield: 1.51%

## Returns
1Y Return: -7.95%

## Profitability
ROE: 17.16%
ROCE: 32.52%
Debt/Equity: 0.02
Revenue Growth: 6.3%
Profit Growth: -39.6%
EBITDA Margin: 35.88%
Operating Margin: 35.15%

## About
Pfizer Ltd is a Drug Manufacturers - General company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - General
Sub Industry: Unknown

## Business Model
Overview: Pfizer Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - General. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Change in Management
- Announcement: Intimation Of Date Of Annual General Meeting
- BSE Filing: Announcement under Regulation 30 (LODR)-Change in Management

## Data Freshness
Quote Updated: 2026-05-25T20:00:13.927Z
Price History Updated: 2026-05-25T05:29:20.240Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:29:20.240Z
Quant Updated: 2026-05-25T05:29:20.240Z
Sentiment Updated: 2026-05-25T05:29:20.240Z
Financials Status: current
Financials Updated: 2026-05-18T08:32:01.351Z
Financials Last Attempt: 2026-05-18T08:32:01.351Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Nov 2007)
Revenue: ₹664 Cr
Operating Profit: ₹127 Cr (OPM 19%)
Net Profit: ₹106 Cr
Tax: ₹163 Cr

## Annual P&L History
Nov 2007: Rev ₹664Cr | PAT ₹106Cr | OPM 19%
Nov 2008: Rev ₹676Cr | PAT ₹340Cr | OPM -21%

## Balance Sheet (Nov 2007)
Total Assets: ₹646 Cr
Total Liabilities: ₹646 Cr
Borrowings: ₹0 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Meenakshi  Nevatia, MD, CEO & Director
- Prajeet  Nair C.S., Director of Corporate Services, Company Secretary & Compliance Officer
- Pazhania Pillai Rengan, Whole-Time Director & Executive Director of Plant Operations
- Anil  Pattanshetty, Senior Director of Business Operations
- Sharad  Goswami, Senior Director of Policy & Public Affairs

---
Source: rupiya.io/stocks/pfizer
Disclaimer: For research and education only. Not investment advice.